HOME >> BIOLOGY >> NEWS
May: Multiple Sclerosis Awareness Month -- latest research is good news

Montreal, QC -- May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then by highlighting the latest research that might offer hope for the 55 to 75, 000 sufferers across Canada. A new drug under investigation for Multiple Sclerosis (MS) appears to be safe and effective according to studies involving researchers at the Montreal Neurological Institute. The studies, presented this week at the American Academy of Neurologys (AAN) 59th Annual Meeting in Boston, also provide deeper insight into the biology of this complex disease. Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases of MS diagnosed each year. MS is the most common neurological disease affecting young adults in Canada and affects 18% of all Quebecers.

The Phase I and Phase II studies involved people in Canada and the USA with relapsing-remitting MS, in which symptoms flare up and then subside. Treatment with the drug rituximab significantly reduced the number of new brain lesions and the frequency of relapses, times when symptoms of MS flare up.

Rituximab is a therapeutic antibody that selectively targets and depletes a set of immune cells called B-cells by binding to a specific protein on their surface.

"This is the first drug to selectively target B-cells in MS and the significance of its effectiveness is two-fold," says Dr. Amit Bar-Or, neurologist at the Montreal Neurological Institute (MNI) at McGill University, Montreal, Canada and lead investigator in the Phase I study. "Not only might it present a significantly improved therapy for patients with relapsing-remitting MS, but it provides a clearer picture of the role that B-cells play in the disease. Its a particularly exciting time and we think meaningful to advancing treatment options for patients."

The Phase I trial was primarily designed to assess the safety
'"/>

Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
Montreal Neurological Institute and Hospital
2-May-2007


Page: 1 2

Related biology news :

1. Alleviating the burden of Multiple Sclerosis
2. Multiple sclerosis progression linked to immune-cell substance
3. Multiple genes permit closely related fish species to mix and match their color vision
4. Multiple genetic flavors may explain autism
5. Multiple sightings of long-lost woodpecker reported
6. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
7. Brain Awareness Week teaches kids how their brains work
8. Breast Cancer Month story tips from Georgetown University Medical Center
9. National Academies advisory: Feb. 15 program for African-American History Month
10. AAAS decries latest stem cell veto
11. Brain, size and gender surprises in latest fossil tying humans, apes and monkeys

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... ... July 20, 2017 , ... VIC Technology Venture Development™ (VIC™), ... of directors. This addition continues to strengthen and diversify VIC’s board. , "We ... Chairman. “He is a highly accomplished business executive with a broad range of experience ...
(Date:7/18/2017)... ... July 18, 2017 , ... Nanomedical Diagnostics, a cutting-edge life ... launch of a new NTA biosensor chip for use with its label-free Agile ... of polyhistidine-tagged (His-tagged) molecules quickly and reliably. , “Recombinant proteins are an ...
(Date:7/18/2017)... Washington, DC (PRWEB) , ... July 18, 2017 ... ... for the Allotrope Framework, and has released the first phase of the Allotrope ... Bio-IT World’s Best Practices Awards were created to “not only elevate the critical ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... and analytical instruments announced the launch of its new line of Heavy-Duty Orbital ... shaker models (both analog and digital) for laboratory applications. These shakers are ...
Breaking Biology Technology:
Cached News: